Domov › Rak dojke › Washington › Tacoma
Klinične študije za Rak dojke v Tacoma, WA
18 študij za Rak dojke išče udeležence na lokacijah v Tacoma in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Madigan Army Medical Center, Tacoma
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Vključevanje udeležencevFaza 3
- Northwest Medical Specialties, Tacoma
- Providence Regional Cancer System, Lacey · 23 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Providence Regional Cancer System-Lacey, Lacey · 23 mi stran
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Vključevanje udeležencevFaza 3
- Research Site, Puyallup · 8 mi stran
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Vključevanje udeležencevFaza 2
- Northwest Medical Specialties, Puyallup · 8 mi stran
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Vključevanje udeležencevFaza 3
- Northwest Medical Specialties, PLLC ( Site 0062), Tacoma
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Tacoma
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Vključevanje udeležencevFaza 3
- Northwest Medical Specialties, Tacoma
- Northwest Medical Specialties, Gig Harbor · 8 mi stran
- Northwest Medical Specialties, Puyallup · 8 mi stran
- in še 1
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Vključevanje udeležencevFaza 3
- Northwest Medical Specialties, PLLC ( Site 0067), Tacoma
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Vključevanje udeležencev
- MultiCare Cancer Institute, Tacoma
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi stran
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Clinical Trial Site, Olympia · 26 mi stran
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- MultiCare Health System, Tacoma
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Vključevanje udeležencevFaza 3
- Northwest Medical Specialties, PLLC, Tacoma
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- MultiCare Cancer Institute - Tacoma, Tacoma
- Northwest Medical Specialties PLLC, Tacoma
- Vista Oncology, Olympia · 26 mi stran
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Northwest Medical Specialties, Tacoma
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi stran
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Vključevanje udeležencevFaza 1/2
- Northwest Medical Specialties, PLLC, Tacoma
BostonGene and Exigent Genomic INsight Study
Vključevanje udeležencevOpazovalna študija
- Northwest Medical Specialities, Puyallup · 8 mi stran
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Tacoma
- Nemalicelični pljučni rak20 študij
- Ulcerativni kolitis15 študij
- Množni mielom13 študij
- Rak prostate11 študij
- Crohnova bolezen11 študij
- Kolorektalni rak9 študij
- Metastatski rak9 študij
- Melanom7 študij
- Rak jajčnikov7 študij
- Rak želodca6 študij
- Rak požiralnika6 študij
- Rak (vse vrste)6 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.